Quality of life assessment in patients with metastatic colorectal cancer receiving maintenance therapy after first-line induction treatment: a preplanned analysis of the phase III... von Quidde, J., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C.A., Killing, B., Depenbusch, R., Steffens, C.-C., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher, A., Tannapfel, A., Trarbach, T., Marschner, N., Schmoll, H.-J., Hinke, A., Al-Batran, S.-E., Arnold, D.

Volltext

Intraperitoneal bevacizumab for control of malignant ascites due to advanced-stage gastrointestinal cancers: A multicentre double-blind, placebo-controlled phase II study – AIO SUP... von Jordan, K, Luetkens, T, Gog, C, Killing, B, Arnold, D, Hinke, A, Stahl, M, Freier, W, Rüssel, J, Atanackovic, D, Hegewisch-Becker, S

Volltext

Phase I study of the humanised anti-EGFR monoclonal antibody matuzumab (EMD 72000) combined with gemcitabine in advanced pancreatic cancer von GRAEVEN, U, KREMER, B, SÜDHOFF, Th, KILLING, B, ROJO, F, WEBER, D, TILLNER, J, ÜNAL, C, SCHMIEGEL, W

Volltext

522PQUALITY OF LIFE (QOL) IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC) RECEIVING MAINTENANCE THERAPY AFTER FIRST-LINE INDUCTIVE TREATMENT: A QOL SUB-ANALYSIS OF THE AIO KRK... von Quidde, J., Arnold, D., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C., Lange, T., Marschner, N., Dietrich, G., Al-Batran, S.

Volltext

Quality of Life (Qol) in Patients with Metastatic Colorectal Cancer (Mcrc) Receiving Maintenance Therapy After First-Line Inductive Treatment: a Qol Sub-Analysis of the Aio Krk 020... von Quidde, J., Arnold, D., Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C., Lange, T., Marschner, N., Dietrich, G., Al-Batran, S.

Volltext

Intraperitoneal Bevacizumab (Bev) for Control of Malignant Ascites Due to Advanced-Stage Gastrointestinal Cancers (Gi): a Multicenter Double-Blind, Placebo (Pl)-Controlled, Randomi... von Jordan, K., Atanackovic, D., Gog, C., Killing, B., Stahl, M., Freier, W., Arnold, D., Rüssel, J., Hinke, A., Luetkens, T., Wagner, S., Späth-Schwalbe, E., Pelzer, U., Medgenberg, D., Hegewisch-Becker, S.

Volltext

1487PDINTRAPERITONEAL BEVACIZUMAB (BEV) FOR CONTROL OF MALIGNANT ASCITES DUE TO ADVANCED-STAGE GASTROINTESTINAL CANCERS (GI): A MULTICENTER DOUBLE-BLIND, PLACEBO (PL)-CONTROLLED, R... von Jordan, K., Atanackovic, D., Gog, C., Killing, B., Stahl, M., Freier, W., Arnold, D., Rüssel, J., Hinke, A., Luetkens, T., Wagner, S., Späth-Schwalbe, E., Pelzer, U., Medgenberg, D., Hegewisch-Becker, S.

Volltext

Maintenance Strategy with Fluoropyrimidines (Fp) Plus Bevacizumab (Bev), Bev Alone or No Treatment, Following a 24-Week First-Line Induction with Fp, Oxaliplatin (Ox) and Bev for P... von Hegewisch-Becker, S., Graeven, U., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C., Al-Batran, S., Lange, T., Dietrich, G., Stoehlmacher, J., Tannapfel, A., Reinacher-Schick, A., Quidde, J., Hinke, A., Arnold, D., Schmoll, H.

Volltext

A Phase III Trial of Fluoropyrimidines (FP) Plus Bevacizumab (BEV) vs. Bev Alone, or No Treatment as Maintenance Strategy, Following a Standard Combination of FP, Oxaliplatin (OX),... von Arnold, D., Lerchenmüller, C., Killing, B., Depenbusch, R., Steffens, C.C., Al-Batran, S.E., Quidde, J., Lange, T., Dietrich, G., Stoehlmacher, J., Reinacher-Schick, A., Tannapfel, A., Graeven, T., Schmoll, H.J., Hegewisch-Becker, S.

Volltext

A Neuro-fuzzy Approach to Machine Vision Based Parts Inspection von Killing, J., Surgenor, B.W., Mechefske, C.K.

Volltext bestellen